Global Companies Flock to Japan’s Advanced Research and Development Ecosystem

Global corporations are increasingly choosing to invest in Japan, drawn by the country's advanced research and development ecosystem, technical expertise, and sophisticated industrial networks. Amid rising geopolitical risks and a growing industry race to commercialize next-generation technologies, executives are seeking trusted research partners and resilient supply chains. The Japanese government aims to nearly double the country’s inward foreign direct investment balance over five years to 2030 through reforms that streamline investment procedures and promote regional innovation clusters.

Several international companies illustrate this trend. German pharmaceutical company Boehringer Ingelheim committed 48.4 billion yen to expand its manufacturing plant in eastern Yamagata Prefecture and utilizes its Kobe Pharma Research Institute for global drug discovery. Similarly, Taiwan’s Anjet Corporation established a base in Kyoto for developing silicon carbide power semiconductors, collaborating closely with local suppliers and universities. Italian electrochemical technology company De Nora Permelec operates manufacturing and research facilities in Fujisawa and Okayama, developing advanced electrodes, electrolysis systems, and lithium recycling technologies for the emerging hydrogen economy.

These corporate investments align with Japan's economic policy agenda, which identifies 17 strategic fields such as artificial intelligence, semiconductors, and drug discovery, with projected public and private investments exceeding 370 trillion yen by fiscal 2040. Through initiatives like the Program for Promotion of Foreign Direct Investment in Japan, the government seeks to encourage foreign enterprises to establish lasting operations, fostering partnerships between foreign and domestic firms to test and scale new technologies globally.